Dysadherin expression in gastrointestinal stromal tumors (GISTs)

Pathology Research and Practice

Volumn 205, Issue 7, 2009, Pages 445-450

  Liang, Jian Fang ^a   Zheng, Hui Xia ^a   Xiao, Hong ^a   Li, Ning ^a   Cheng, Cai Xia ^a   Wang, Hong Kun ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Dysadherin; E cadherin; Expression; GISTs

Indexed keywords

DYSADHERIN; MESSENGER RNA; UVOMORULIN;

ADULT; AGE; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RISK; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; FEMALE; GASTROINTESTINAL STROMAL TUMORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, MESSENGER; YOUNG ADULT;

EID: 67349228184     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2008.12.020     Document Type: Article

References (21)

1. Miettinen M., Sobin L.H., and Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am. J. Surg. Pathol. 29 (2005) 52-68
2. Franquemont D.W. Differentiation and risk assessment of gastrointestinal stromal tumors. Am. J. Clin. Pathol. 103 (1995) 41-47
3. Ino Y., Gotoh M., Sakamoto M., et al. Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. Proc. Natl. Acad. Sci. USA 99 (2002) 365-370
4. Shimamura T., Yasuda J., Ino Y., et al. Dysadherin expression facilitates cell motility and metastatic potential of human pancreatic cancer cells. Cancer Res. 64 (2004) 6989-6995
5. Gupta A., Deshpande C.G., and Badve S. Role of E-cadherins in development of lymphatic tumor emboli. Cancer 97 (2003) 2341-2347
6. Nakanishi Y., Akimoto S., Sato Y., et al. Prognostic significance of dysadherin expression in tongue cancer: immunohistochemical analysis of 91 cases. Appl. Immunohistochem. Mol. Morphol. 12 (2004) 323-328
7. Sato H., Ino Y., Miura A., et al. Dysadherin: expression and clinical significance in thyroid carcinoma. J. Clin. Endocrinol. Metab. 88 (2003) 4407-4412
8. Shimamura T., Sakamoto M., Ino Y., et al. Dysadherin overexpression in pancreatic ductal adenocarcinoma reflects tumor aggressiveness: relationship to E-cadherin expression. J. Clin. Oncol. 21 (2003) 659-667
9. Aoki S., Shimamura T., Shibata T., et al. Prognostic significance of dysadherin expression in advanced colorectal carcinoma. Br. J. Cancer 88 (2003) 726-732
10. Shimada Y., Yamasaki S., Hashimoto Y., et al. Clinical significance of dysadherin expression in gastric cancer patients. Clin. Cancer Res. 10 (2004) 2818-2823
11. Izumi T., Oda Y., Hasegawa T., et al. Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Mod. Pathol. 19 (2006) 820-831
12. Miettinen M., and Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin. Diagn. Pathol. 23 (2006) 70-83
13. Schneider-Stock R., Boltze C., Lasota J., et al. Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study. Clin. Cancer Res. 11 (2005) 638-645
14. Bryant D.M., and Stow J.L. The ins and outs of E-cadherin trafficking. Trends Cell Biol. 14 (2004) 427-434
15. Miettinen M., and Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch. Pathol. Lab. Med. 130 (2006) 1466-1478
16. Dematteo R.P., Heinrich M.C., El-Rifai W.M., et al. Clinical management of gastrointestinal stromal tumors: before and after STI-571. Hum. Pathol. 33 (2002) 466-477
17. Smith M.E., Brown J.I., and Fisher C. Epithelioid sarcoma: presence of vascular-endothelial cadherin and lack of epithelial cadherin. Histopathology 33 (1998) 425-431
18. Graff J.R., Gabrielson E., Fujii H., et al. Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J. Biol. Chem. 275 (2000) 2727-2732
19. Becker K.F., Atkinson M.J., Reich U., et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 54 (1994) 3845-3852
20. Matsuyoshi N., Hamaguchi M., Taniguchi S., et al. Cadherinmediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts. J. Cell Biol. 118 (1992) 703-714
21. Wu D., Qiao Y., Kristensen G.B., et al. Prognostic significance of dysadherin expression in cervical squamous cell carcinoma. Pathol. Oncol. Res. 10 (2004) 212-218